Cystic Fibrosis Foundation Sells Drug Royalties for $3B

The Cystic Fibrosis Foundation will sell royalties it gets from Vertex Pharmaceuticals Inc. for $3.3 billion to Royalty Pharma, taking a profit from charitable investments made to fight the fatal lung disease.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.